Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Acq. announced

NRX Pharmaceuticals, Inc. (NRXP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Javitt Jonathan C (Chief Scientist) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Bought 100,000 shares @ $0.33, valued at $33k
08/23/2023 4 Javitt Jonathan C (Chief Scientist) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Bought 200,000 shares @ $0.322, valued at $64.4k
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2022 4 Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Sold 133,719 shares @ $1.02, valued at $136.4k
Sold 33,018 shares @ $1.0523, valued at $34.7k
11/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/02/2022 4 Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Sold 784,063 shares @ $1.0094, valued at $791.4k
07/05/2022 4 Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Gifted 2,000,000 shares @ $0
06/07/2022 4 Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Sold 243,596 shares @ $0.7024, valued at $171.1k
Sold 115,657 shares @ $0.6653, valued at $76.9k
Sold 86,459 shares @ $0.6461, valued at $55.9k
06/02/2022 4 Javitt Jonathan C (Chief Scientist) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Bought 100,000 shares @ $58, valued at $5.8M
03/10/2022 4 Besthof Robert (Interim CEO) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Granted 100,000 options to buy @ $2.61, valued at $261k
11/02/2021 4 McMaster Herbert Raymond (Director) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Exercised 18,300 shares @ $2.22, valued at $40.6k
Converted 28,724 options to buy @ $2.22, valued at $63.8k
Granted 10,424 restricted stock units @ $0
11/02/2021 4 Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Gifted 434,594 shares @ $0
11/02/2021 4 Daigneault Alessandra (General Counsel & Secretary) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Exercised 27,395 shares @ $3.07, valued at $84.1k
Sold 33,715 shares @ $13.11, valued at $442k
Exercised 18,420 shares @ $3.07, valued at $56.5k
Exercised 13,164 shares @ $3.07, valued at $40.4k
Converted 43,000 options to buy @ $3.07, valued at $132k
Granted 15,605 restricted stock units @ $0
Converted 28,916 options to buy @ $3.07, valued at $88.8k
Converted 20,666 options to buy @ $3.07, valued at $63.4k
Granted 10,496 restricted stock units @ $0
Granted 7,502 restricted stock units @ $0
11/02/2021 4 Besthof Robert (Chief Comm. & Patient Officer) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Exercised 63,710 shares @ $0.2, valued at $12.7k
Sold 40,000 shares @ $11.76, valued at $470.4k
Converted 100,000 options to buy @ $0.2, valued at $20k
Granted 36,290 restricted stock units @ $0
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Granted 13,971,864 shares @ $0
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Gorovitz Aaron (Director) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Granted 8,336 shares @ $0
Granted 8,336 shares @ $0
Granted 8,336 shares @ $0
Granted 16,678 shares @ $0
06/10/2021 4 Glied Sharon (Director) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Granted 13,168 shares @ $0
Granted 65,437 options to buy @ $0.21, valued at $13.7k
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Flynn Patrick John (Director) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Granted 362,332 shares @ $0
Granted 35,209 shares @ $0
Granted 35,209 shares @ $0
Granted 692,639 warrants @ $3.08, valued at $2.1M
Granted 692,639 warrants @ $3.08, valued at $2.1M
06/10/2021 4 Daigneault Alessandra (General Counsel & Secretary) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Granted 6,320 shares @ $0
Granted 143,840 options to buy @ $3.08, valued at $443k
Granted 49,600 options to buy @ $3.08, valued at $152.8k
Granted 148,800 options to buy @ $72.3, valued at $10.8M
06/10/2021 4 Besthof Robert (Chief Comm. & Patient Officer) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Granted 347,200 options to buy @ $0.21, valued at $72.9k
Granted 347,200 options to buy @ $3.08, valued at $1.1M
05/25/2021 4 Big Rock Partners Sponsor, LLC (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.
Txns: Disposed/sold 5,435 shares @ $0
Converted 27,250 shares @ $0
Converted 272,500 options to buy @ $0
Bought 100,000 options to buy @ $10, valued at $1M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy